EMV
Director Trades
| Date | Director | Value |
|---|
Company News
EMVision Medical Devices Activates New US Site for Pivotal emu Brain Scanner Trial
Premier US stroke research hub UCLA Health will act as the site for a validation trial and continuous innovation study of EMVision Medical Devices’ (ASX: EMV) new emu brain scanner. The trial site will be led by principal investigator Dr May Nour, a dually-trained vascular and interventional neurologist and medical director of California’s first mobile […]
EMVision Medical Devices’ First Responder passes aeromedical testing for stroke and TBI care
EMVision Medical Devices (ASX: EMV) has completed aeromedical retrieval environment testing of its First Responder proof-of-concept (PoC) device to treat rural patients with stroke and traumatic brain injury (TBI). The company used the world-first brain imaging device to collect a series of volunteer scans in remote settings in collaboration with the Royal Flying Doctor Service […]
EMVision Medical Devices’ interim trial data shows promising results in identifying stroke types
Stage 2 interim data from a pre-validation trial by EMVision Medical Devices (ASX: EMV) has confirmed the positive performance of neurodiagnostic artificial intelligence (AI) algorithms in the diagnosis of suspected haemorrhagic or ischaemic strokes. The data showed the algorithms had an “encouraging ability” to identify patterns and features across complex ischaemic patient data sets, including […]
EMVision Medical Devices receives milestone payment for second-generation first responder brain scanner
EMVision Medical Devices (ASX: EMV) has received a $600,000 payment after achieving an “important milestone” for its second-generation first responder stroke detection device. The payment comes from the Australian Stroke Alliance, as part of the Commonwealth of Australia Medical Research Future Fund program. Under a project agreement with the Australian Stroke Alliance, EMVision will receive […]
EMVision receives $5m grant to advance brain scanning technology for stroke management
Australian medtech EMVision Medical Devices (ASX: EMV) has been awarded $5 million in non-dilutive cash funding under the Australian Federal Government’s modern manufacturing initiative (MMI). The company is one of four businesses in New South Wales to take a share of the $23 million pool available under the MMI’s integration and translation stream. This grant will […]
EMVision’s ground-breaking product developments continue as cash reserves rise
EMVision Medical Devices (ASX: EMV) has announced its device development and multi-centre clinical trial preparation is progressing positively, with the company capping off its latest quarter being well funded. The company, as at 31 March 2022, holds cash reserves of $8.5 million, with it significantly benefiting from substantial non-dilutive cash funding during the financial year […]
EMVision Medical Devices adds respected stroke care experts to clinical advisory board
Queensland-based EMVision Medical Devices (ASX: EMV) has added three respected experts in the field of stroke care to its clinical advisory board. Neurologists Professor Geoffrey Donnan and Professor Stephen Davis will join the board in an ex-officio capacity as co-chairs of the Australian Stroke Alliance. They will be joined on the Clinical Advisory Board, also […]
EMVision Medical Devices inks VNA supply deal with Keysight Technologies
Medical imaging technology company EMVision Medical Devices (ASX: EMV) has revealed it has secured a strategic deal with New York-listed Keysight Technologies (NYSE: KEYS) for the exclusive supply of “fast sweep” feature vector network analysers (VNA) to use in the field of neuroimaging. EMVision emerged from a trading halt today to announce the original equipment […]
EMVision Medical Devices progresses portable brain scanner for stroke patients towards commercialisation
EMVision Medical Devices (ASX: EMV) has continued advancing development and commercialisation plans of its portable brain scanner machine for stroke patients. During the half year ending December 2021 (H1 FY2022), EMVision progressed its portable brain scanner technology – underpinned by “encouraging results” from the first clinical trial on stroke patients at Brisbane’s Princess Alexandra Hospital […]
EMVision makes design improvements to portable brain scanning machine for stroke patients
Queensland-based EMVision Medical Devices (ASX: EMV) has reported significant advances to the design and engineering of its first-generation portable brain scanning machine prior to commercialisation. Improvements and upgrades have been made to the device’s antennae, coupling liquid, decoupling media, headset membrane and shielding to enhance durability, reliability and performance. EMVision has also selected the most […]
